1- Gu L, Cao C, Fu J, Li Q, Li DH2, Chen MY.Serum adiponectin in breast cancer. A meta-analysis. Medicine. 2018 ;97 (29):p e11433. 2- Marseglia L, Manti S, D'Angelo G, Nicotera A, Parisi E, Di Rosa G, Gitto E, Arrigo T. Oxidative stress in obesity: a critical component in human diseases. Int J Mol Sci. 2014; 16(1):378-400. 3- Nalabolu MR, Palasamudram K, Jamil K. Adiponectin and leptin molecular actions and clinical significance in breast cancer. Int J Hematol Oncol Stem Cell Res 2014;8:31–40. 4- Francke S, Manraj M, Lacquemant C, Lecoeur C, Leprêtre F, Passa P, Hebe A, Corset L, Yan SL, Lahmidi S, Jankee S, Gunness TK, Ramjuttun US, Balgobin V, Dina C, Froguel P. A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum Mol Genet. 2001;10(24):2751-65. 5- Lu JF, Zhou Y, Huang GH, Jiang HX, Hu BL, Qin SY. Association of ADIPOQ polymorphisms with obesity risk: a meta-analysis. Hum Immunol. 2014; 75(10):1062-8. 6- Díez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur. J. Endocrinol. 2003;148 (3): 293–300. 7- Chen J, Tan B, Karteris E, Zervou S, Digby J, Hillhouse EW, Vatish M, Randeva HS. Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines. Diabetologia. 2006;49 (6): 1292–302. 8- Ukkola O, Santaniemi M. Adiponectin: a link between excess adiposity and associated comorbidities? J. Mol. Med. 2002;80 (11): 696–702. 9- Cawthorn WP, Scheller EL, Learman BS, Parlee SD, Simon BR, Mori H, Ning X, Bree AJ, Schell B, Broome DT, Soliman SS, DelProposto JL, Lumeng CN, Mitra A, Pandit SV, Gallagher KA, Miller JD, Krishnan V, Hui SK, Bredella MA, Fazeli PK, Klibanski A, Horowitz MC, Rosen CJ, MacDougald OA. Bone marrow adipose tissue is an endocrine organ that contributes to increased circulating adiponectin during caloric restriction. Cell Metab. 2014;20 (2): 368–375. 10- Gulcelik MA, Colakoglu K, Dincer H, Dogan L, Yenidogan E, Gulcelik NE. Associations between adiponectin and two different cancers: breast and colon. Asian Pac J Cancer Prev. 2012; 13(1):395-8. 11- Karaduman M, Bilici A, Ozet A, Sengul A, Musabak U, Alomeroglu M. Tissue levels of adiponectin in breast cancer patients. Med Oncol. 2007; 24(4):361-6. 12- Bråkenhielm E, Veitonmäki N, Cao R, Kihara S, Matsuzawa Y, Zhivotovsky B, Funahashi T, Cao Y. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci U S A. 2004; 101(8):2476-81. 13- Tworoger SS, Eliassen AH, Kelesidis T, Colditz GA, Willett WC, Mantzoros CS, Hankinson SE. Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab. 2007;92:1510–1516. http://dx.doi.org/10.1210/jc.2006-1975. 14- Minatoya M, Kutomi G, Asakura S, Otokozawa S, Sugiyama Y, Ohnishi H, Akasaka H, Miura T, Mori M, Hirata K. Relationship of serum isoflavone, insülin and adiponectin levels with breast cancer risk. Breast Cancer. 2015;22:452–461. http://dx.doi.org/10.1007/s12282-013-0502-2. 15- Ye J, Jia J, Dong S, Zhang C, YYu S, Li L, Mao C, Wang D, Chen J, Yuan G. Circulating adiponectin levels and the risk of breast cancer: a meta-analysis. Eur J Cancer Prev. 2013;23:158–165. http://dx.doi.org/10.1097/CEJ.0b013e328364f293. 16- Llanos AAM, Brasky TM, Mathew J, Makambi KH, Marian C, Dumitrescu R, Freudenheim JL, Shields PG. Genetic variation in adipokine genes and association with adiponectin and leptin concentrations in plasma and breast tissue. Cancer Epidemiol Biomarkers Prev. 2014;23(8): 1559–68. DOI: 10.1158/1055-9965.EPI-14-0173 17- Wozniak SE, Gee LL, Wachtel MS, Frezza EE. Review Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci. 2009; 54(9):1847-56. 18- Juge-Aubry CE, Henrichot E, Meier CA. Review Adipose tissue: a regulator of inflammation. Best Pract Res Clin Endocrinol Metab. 2005; 19(4):547-66. 19- Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia. 2003; 46(4):459-69. 20- Van der Burg B, Rutteman GR, Blankenstein MA, de Laat SW, van Zoelen EJ. Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: synergistic action of insulin and estrogen. J Cell Physiol. 1988; 134(1):101-8. 21- Vona-Davis L, Howard-McNatt M, Rose DP. Review Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer. Obes Rev. 2007; 8(5):395-408. 22- Mohan Reddy N, Kalyana Kumar CH, Jamil Kaiser. Association of adiponectin gene functional polymorphism (+45T/G and 276G/T) with obese breast cancer. J Mol Biomark Diagn 2012;3:138. doi:10.4172/2155-9929.1000138. 23- Kaklamani VG, Sadim M, Hsi A, Offit K, Oddoux C, Ostrer H, Ahsan H, Pasche B, Mantzoros C. Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk. Cancer Res. 2008; 68(9): 3178-3184. doi: 10.1158/0008-5472.CAN-08-0533 24- Nyante SJ, Gammon MD, Kaufman JS, Bensen JT, Lin DY, Barnholtz-Sloan JS, Hu Y, He Q, Luo J, Millikan RC. Common genetic variation in adiponectin, leptin, and leptin receptor and association with breast cancer subtypes. Breast Cancer Res Treat. 2011;129(2):593-606. doi: 10.1007/s10549-011-1517-z. 25- Yang Y, Zhang F, Ding R, Skrip L, Wang Y, Lei H, Hu D. ADIPOQ gene polymorphisms and cancer risk: a meta-analysis. Cytokine. 2013;61(2):565-71. doi: 10.1016/j.cyto.2012.10.030. 26- Kaklamani V, Yi N, Zhang K, Sadim M, Offit K, Oddoux C, Ostrer H, Mantzoros C, Pasche B. Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk. Metabolism. 2011;60(9):1234-43. 27- Zhang BC, Li WM, Xu YW. A meta-analysis of the association of adiponectin gene polymorphisms with coronary heart disease in Chinese Han population. Clin Endocrinol (Oxf). 2012 ;76(3):358-64. 28- Ouyang S, Cao D, Liu Z, Ma F, Wu J. Meta-analysis of the association of ADIPOQ G276T polymorphism with insulin resistance and blood glucose. Endocrine. 2014;47(3):749-57.